ACS Omega · 2019 · 12 citations · 25 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoverySynthetic Medicinal ChemistryNatural Product-based Drug DesignRetrosynthetic AnalysisAgonist ActivityConjugate AdditionErgot AlkaloidsMedicinal HeterocyclesNatural Product Total SynthesisPyrolytic EliminationRing-closing MetathesisTotal Synthesis-derived Analogues
A potent dopamine (D2) receptor agonist (±)-quinagolide, which is used for the treatment of hyperprolactinemia, was synthesized using the ring closing metathesis (RCM) approach from meta-hydroxybenzaldehyde as the starting material. The key features of this synthesis are pyrolytic elimination, late-stage expedient synthesis of functionalized trans-fused tetrahydropyridine-3-carboxylates from olefin 6, via conjugate addition–elimination upon acetate 11, followed by RCM and phenyliodine bis(trifluoroacetate) (PIFA)-mediated Hofmann rearrangement of piperidine-3-carboxamide, which enables the synthesis of 3-aminopiperidine skeleton of quinagolide. For the total synthesis of natural products such as ergot alkaloids, late-stage synthesis of functionalized trans-fused tetrahydropyridine-3-carboxylates using RCM and PIFA-mediated Hofmann rearrangement of piperidine-3-carboxamide, which allows quick access to the synthetically challenging 3-aminopiperidine skeleton, are the main achievements of the present work.
25
Formation of medium-ring heterocycles by diene and enyne metathesis
Shital K. Chattopadhyay, Swastik Karmakar, Titas Biswas et al. · Tetrahedron · 2007 · 201 citations